Prosecution Insights
Last updated: April 17, 2026
Application No. 15/359,018

Processing Method for Poultry Oil

Non-Final OA §103§112
Filed
Nov 22, 2016
Examiner
ZILBERING, ASSAF
Art Unit
1792
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kai-Neng Hwang
OA Round
12 (Non-Final)
33%
Grant Probability
At Risk
12-13
OA Rounds
4y 9m
To Grant
60%
With Interview

Examiner Intelligence

Grants only 33% of cases
33%
Career Allow Rate
206 granted / 619 resolved
-31.7% vs TC avg
Strong +27% interview lift
Without
With
+27.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 9m
Avg Prosecution
81 currently pending
Career history
700
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
57.9%
+17.9% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
26.0%
-14.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 619 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Status of Claims Note: The amendment of May 19th 2025 has been considered. Claims 1-14, 16-17 and 25 are cancelled. Claim 26 was added. Claims 15, 18-24 and 26 are pending and examined in the current application. Any rejections not recited below have been withdrawn. Claim Rejections - 35 USC § 112 The text of those sections of Title 35 of the U.S. Code not included in this action can be found in a prior Office action. Claim 26 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the enablement requirement. The claim contains subject matter which was not described in the specification in such a way as to enable one skilled in the art to which it pertains, or with which it is most nearly connected, to make and/or use the invention. To be enabling, the specification of the patent must teach those skilled in the art how to make and use the full scope of the claimed invention without undue experimentation. In re Wright, 999 F.2d 1557, 1561 (Fed. Cir. 1993). Explaining what is meant by "undue experimentation," the Federal Circuit has stated: The test is not merely quantitative, since a considerable amount of experimentation is permissible, if it is merely routine, or if the specification in question provides a reasonable amount of guidance with respect to the direction in which the experimentation should proceed to enable the determination of how to practice a desired embodiment of the claimed invention. PPG v. Guardian, 75 F.3d 1558, 1564 (Fed. Cir. 1996). The factors that may be considered in determining whether a disclosure would require undue experimentation are set forth by In re Wands, 8 USPQ2d 1400 (CAFC 1988) at 1404 where the court set forth the eight factors to consider when assessing if a disclosure would have required undue experimentation. Citing Ex parte Forman, 230 USPQ 546 (BdApls 1986) at 547 the court recited eight factors: the quantity of experimentation necessary, the amount of direction or guidance provided, the presence or absence of working examples, the nature of the invention, the state of the prior art, the relative skill of those in the art, the predictability of the art, and the breadth of the claims. These factors are always applied against the background understanding that scope of enablement varies inversely with the degree of unpredictability involved. In re Fisher, 57 CCPA 1099, 1108,427 F.2d 833,839, 166 USPQ 18, 24 (1970). Keeping that in mind, the Wands factors are relevant to the instant fact situation for the following reasons: The nature of the invention, state and predictability of the art, and relative skill level: The invention relates to crude fat fractionation and separation of the fractions by using centrifuge filtration. The relative skill of those in the art is above average. The breadth of the claims: Since the instant specification provides no limiting definition or description of the radius of the centrifuge’s rotor, the rotation per minute (‘rpm’) recited in claim 26 encompasses a very broad relative centrifugal force (‘RCF’) or g-force. The amount of direction or guidance provided and the presence or absence of working examples: The specification provides no direction or guidance for practicing the claimed invention in its “full scope”. NO reasonably specific guidance is provided concerning the pressure/force to be applied in order to filter the fractioned crude poultry oil. The quantity of experimentation necessary: Since the quality and quantity of the oil produced depends on the rate it is filtered, and since the rate of filtration through centrifuge filtration depends on the g-force applied, which depends on the rotation rate and the radius of the rotor. The absence of experimental evidence, or disclosure of the radius of the rotor, renders the current process non-enabling to a skilled artisan as it fails to comply with the enablement requirement of 35 USC §112(a). Claim Rejections - 35 USC § 103 The text of those sections of Title 35 of the U.S. Code not included in this action can be found in a prior Office action. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 15, 18, 21, 23 and 24 are rejected under 35 U.S.C. 103 as being unpatentable over NPL Arnaud et al., “Chicken fat dry fractionation: Effects of temperature and time on crystallization, filtration and fraction properties” (‘Arnaud1’), NPL Arnaud et al., “Suitable cooling program for chicken fat dry fractionation” (‘Arnaud2’) (from Eur. J. Lipid Sci. Technol. 109 (2007) 127-133), NPL Arnaud et al., “Thermal characterization of chicken fat dry fractionation process” (‘Arnaud3’) (from Journal of Food Engineering 72(2006) 390-397) and NPL Timms., “Fractional Crystallisation – The Fat Modification Process for The 21st Century” (from Malaysian Oil Science and Technology 2005, Vol. 14, No. 1). Regarding claims 15, 18, 21 and 23: Arnaud1, Arnaud2 and Arnaud3 disclose dry fractionating crude chicken fat, where the fat is heated up above the melting point of the fat to form chicken oil, and then slowly cooled down to a desired temperature and the formed solid fat crystals (i.e., stearin) are removed from the fat via filtration or centrifugation leaving the liquid oil (i.e., olein) behind (see Arnaud1 pages 239-241; Arnaud2 page 127-129 and Arnaud3 390-394) and Timms discloses that crystallizing fat during fat fractionation, by standing at a predetermined temperature is well known and conventional in the art (see Timms abstract; sections 2.1-2.3 and page 5, right column). Moreover, Arnaud1 specifically discloses an example where the solid fat crystals were collected at 14.3 ºC (see Arnaud1 page 243). As to frying or boiling fatty tissues of poultry and removing impurities of dregs or water to obtain crude poultry oil recited in claim 15: Arnaud1, Arnaud2 and Arnaud3 disclose obtaining the crude chicken fat by melting the fat and eliminating the collagenic by-products by filtration and liquid fractionation by decantation (see Arnaud1, section 2.1; Arnaud2, section 2.1; Arnaud3, section 2.2), which reads on the claimed limitations. As to standing the crude poultry oil recited in claim 15 and 18: Arnaud1, Arnaud2 and Arnaud3 disclose of continuous gentle stirring; However, Timms discloses that a gentle stirring followed by no agitation provides for better nucleation and large crystal growth (see Timms section 2.2-2.3). Therefore, it would have been obvious to a skilled artisan to have cooled the crude chicken oil while gently stirring followed by no agitation, in order to provide better nucleation and large crystal growth, and thus arrive at the claimed limitations. As to the temperatures, durations and stirring rates recited in claims 15-18: Arnaud1, Arnaud2 and Arnaud3 disclose dry fractionating crude chicken fat, where the fat is heated up above the melting point of the fat to form chicken oil, and then slowly cooled down to a desired temperature and the formed solid fat crystals (i.e., stearin) are removed from the fat via filtration or centrifugation leaving the liquid oil (i.e., olein) behind (see Arnaud1 pages 239-241; Arnaud2 page 127-129 and Arnaud3 390-394), but fail to disclose the temperatures and durations recited; However, Arnaud1, Arnaud2, Arnaud3 and Timms disclose the physical/textural properties of the fractions depend on the temperature and duration of crystallization (see Arnaud1 whole document, Arnaud2 whole document, Arnaud3 whole document and Timms pages 3-5) and the rate of stirring (gentle agitation and/or no agitation) to encourage development of large crystals is well known (see Timms page 3, left column). Therefore, it would have been obvious to a skilled artisan to have modified Arnaud1, Arnaud2 and Arnaud3 and to have adjusted the fractionation temperature, duration and stirring rates in order to attain fat with desired physical/textural properties and thus arrive at the claimed limitations. As set forth in MPEP §2144.05 discovering an optimum value of a result effective variable, involves only routine skill in the art. Moreover regarding the agitation rates recited in claim 15: Arnaud3 discloses agitating the fat during crystallization was well known and conventional (see Arnaud3 page 391; figure 1). Moreover, Arnaud1, Arnaud2 and Arnaud3 disclose of using variable-speed agitator during crystallization (see Arnaud1 page 240, left column; Arnaud2 page 128, left column; and Arnaud3 page 391). Arnaud1, Arnaud2 and Arnaud3 disclose of using agitation rates that are higher than the rate recited in claim 15, Arnaud3 discloses that using slow agitation rate allows for a homogenous temperature without breaking crystals being formed (see Arnaud3 page 391) and Timms discloses the rate of stirring (gentle agitation and/or no agitation) to encourage development of large crystals is well known (see Timms page 3, left column). Therefore, it would have been obvious to a skilled artisan at the time the application was filed to have modified Arnaud1, Arnaud2 and Arnaud3 and to have adjusted the agitation rate and standing time in order to encourage the development of large crystals and to maintain homogenous temperature without breaking crystals being formed, and thus arrive at the claimed limitations. As set forth in MPEP §2144.05 discovering an optimum value of a result effective variable, involves only routine skill in the art. Regarding claim 24: Given the fact that dry fractionation is known to provide stearin fractions with a higher saturated fatty acid content and olein fractions with higher unsaturated fatty acid content (see Arnaud3 introduction on page 390) and since the crude oil is a mixture of the olein and stearin fractions, the harvested poultry oil (i.e., olein fraction) clearly has higher monounsaturated fatty acid content than the crude oil. Claims 19 and 20 are rejected under 35 U.S.C. 103 as being obvious over NPL Arnaud1, Arnaud2, Arnaud3 and Timms as applied to claims 15, 18, 21, 23 and 24 above, and further in view of Kaas (USPat.Pub 2006/0268659 A1). Regarding claims 19 and 20: Arnaud3 discloses agitating the fat during crystallization was well known and conventional (see Arnaud3 page 391; figure 1). Moreover, Arnaud1, Arnaud2 and Arnaud3 disclose of using variable-speed agitator during crystallization (see Arnaud1 page 240, left column; Arnaud2 page 128, left column; and Arnaud3 page 391). Arnaud1, Arnaud2 and Arnaud3 disclose of using agitation rates that are higher than the rate recited in claim 9, Arnaud3 discloses that using slow agitation rate allows for a homogenous temperature without breaking crystals being formed (see Arnaud3 page 391) and Timms discloses the rate of stirring (gentle agitation and/or no agitation) to encourage development of large crystals is well known (see Timms page 3, left column), but Arnaud1, Arnaud2, Arnaud3 and Timms fail to disclose using a mixer paddle with silicone pads attached wherein the silicone pads are configured to scrape the an inner wall of the mixing bowl; However, Kaas discloses using a mixer paddle with silicone pads attached wherein the silicone pads are configured to scrap the inner wall of the mixing bowl to provide better mixing (see Kaas abstract; paragraphs [0006]-[0008]; figures 1-5). Therefore, it would have been obvious to a skilled artisan at the time the application was filed to have modified Arnaud1, Arnaud2, Arnaud3 and Timms and to have used a mixer paddle with silicone pads attached wherein the silicone pads are configured to scrap the inner wall of the mixing bowl to provide better mixing, and thus arrive at the claimed limitations. Claims 22 and 26 are rejected under 35 U.S.C. 103 as being obvious over NPL Arnaud1, Arnaud2, Arnaud3 and Timms as applied to claims 15, 18, 21, 23 and 24 above, and further in view of Seynaeve et al (EP 0651046 A1) and Boroughs et al. (US 3,670,888). Regarding claims 22 and 26: Arnaud1, Arnaud2 and Arnaud3 disclose dry fractionating crude chicken fat, where the fat is heated up above the melting point of the fat and slowly cooled down to a desired temperature and the formed solid fat crystals (i.e., stearin) are removed from the fat via filtration leaving the liquid oil (i.e., olein) behind (see Arnaud1 pages 239-241; Arnaud2 page 127-129 and Arnaud3 390-394). While Arnaud1, Arnaud2 and Arnaud3 disclose examples where the stearin was filtered out of the olein for 20 minutes using pressure (see Arnaud1 page 240, left column; Arnaud2 page 128, left column and Arnaud3 page 390, left column), Arnaud1, Arnaud2 and Arnaud3 fail to disclose using centrifuge to provide the pressure/force to push the filtrate through the filter; However, Seynaeve discloses in example 2 on page 5, that centrifuge filtering (i.e., filtration over a laboratory basket centrifuge, where filtration bags are used) of stearin fraction out of olein fraction, is well known and conventional, and Boroughs claims that separating solid fat fraction (i.e., crystalized solid fat (e.g., wax)) from hot liquid oil by basket centrifuge is superior to other separation means, and that rotating the centrifuge at 50-1,000 RPM and using nylon filter bag as the filtration medium provides solid fat crystals larger than 50µm (see Boroughs abstract; column 1, lines 26-33 and 50-75; Examples 1 and 2), which encompasses the rotation speed recited in claim 26, and also reads on nylon filter bag with pore size of 50µm, as a nylon filter bag with pore size of 50µm will clearly separate solid fat crystals larger than 50µm as disclosed in Boroughs. Accordingly, it would have been an obvious matter of choice to a skilled artisan at the time the application was filed to have modified Arnaud1, Arnaud2 and Arnaud3 and to have used centrifuge filtering using nylon filter bag with a pore size of 50µm at a rate encompassing the rotation speed in claim 26 in order to separate the stearin fraction from the olein fraction, as known and conventional in the art, and thus arrive at the claimed limitations. Response to Arguments Applicant's arguments filed on May 19th 2025 have been fully considered but they are not persuasive. Applicant argues on pages 4-8 of the “Remarks” that the prior art references fail to render the claimed invention obvious, because the statement in the introduction of Arnaud 3 discloses that “fat consists of a mixture of triglycerides with different melting points. The fat dry fractionation process involves selective crystallization of the highest melting point triglycerides followed by filtration. This leads to separation of a solid fraction (stearin) with a higher saturated fatty acid content and a liquid fraction (olein) with a higher unsaturated fatty acid content” lacks evidentiary support, as the document Arnaud3 relies on, “Characterisation of chicken fat dry fractionation at the pilot scale” (‘Arnaud4’) teaches in table 2 that dry fractionation of chicken fat provides a stearin fraction comprising 46.1% saturated fatty acids and 53.9% unsaturated fatty acids (MUFA+PUFA), and an olein fraction comprising only 13.9% saturated fatty acids and 69.7% unsaturated fatty acids, which is within 5% o4f the original fat (i.e., pre-fractioned mixture of triglycerides). The Applicant asserts that further evidence is needed. The examiner respectfully disagrees. Table 2 in Amaud4 teaches dry fractionation of chicken fat provides a stearin fraction with higher saturated fatty acids content (i.e., 46.1%) versus an olein fraction with lower saturated fatty acids content (i.e., %13.9) and higher unsaturated fatty acids (i.e., 69.7%), whereas the stearin fraction comprises lower unsaturated fatty acids (i.e., 53.9%), which clearly supports the assertion in Amaud3 that dry fractionation separates a mixture of triglycerides into a stearin fraction with higher saturated fatty acids content and an olein fraction with higher unsaturated fatty acids content. It is noted that Table 1 in Amaud4 where the results of another dry fractionation of chicken fat provides similar results where the stearin fraction comprises 43.5% saturated fatty acids and an olein fraction comprising lower saturated fatty acids content (i.e., 27.4%), and where the olein fraction comprises higher unsaturated fatty acids content (i.e., 72.6%) than the stearin fraction (i.e., 56.5%). Accordingly, Arnoud4 clearly supports the assertion in Arnoud3 that dry fractionation separates a mixture of triglycerides into a stearin fraction with higher saturated fatty acids content and an olein fraction with higher unsaturated fatty acids content. In arguendo, even if Arnaud1 is misinterpreted to compare the saturated and unsaturated fatty acids in stearin and olein fractions to the original unfractionated fat, the data provided in Arnaud4 clearly supports that interpretation in table 2: pre-fractionated chicken fat comprises 33.3% saturated fatty acids and 66.7% unsaturated fatty acids and dry fractionation provided a stearin fraction comprising 46.1% saturated fatty acids and 53.9% unsaturated fatty acids (MUFA+PUFA), and an olein fraction comprising only 13.9% saturated fatty acids and 69.7% unsaturated fatty acids. Arnaud4 also supports that interpretation in table 1: pre-fractionated chicken fat comprises 30.3% saturated fatty acids and 69.7% unsaturated fatty acids and dry fractionation provided a stearin fraction comprising 43.5% saturated fatty acids and 56.5% unsaturated fatty acids (MUFA+PUFA), and an olein fraction comprising only 27.4% saturated fatty acids and 72.6% unsaturated fatty acids. Lastly, it is unclear where Applicant had attained the 5% margin of error assumption. Applicant argues on pages 8-17 of the “Remarks” that the prior art references fail to render the claimed invention obvious, because Arnaud4 and Arnaud3 are aware that dry fractionation provides stearin and olein fractions with fatty acid profiles and melting points that are similar to the original triglyceride mixtures, which contradicts the disclosure in Arnaud1 that “fat consists of a mixture of triglycerides with different melting points. The fat dry fractionation process involves selective crystallization of the highest melting point triglycerides followed by filtration. This leads to separation of a solid fraction (stearin) with a higher saturated fatty acid content and a liquid fraction (olein) with a higher unsaturated fatty acid content”. The examiner respectfully disagrees. As discussed above, the statement in Arnaud1 that “fat consists of a mixture of triglycerides with different melting points. The fat dry fractionation process involves selective crystallization of the highest melting point triglycerides followed by filtration. This leads to separation of a solid fraction (stearin) with a higher saturated fatty acid content and a liquid fraction (olein) with a higher unsaturated fatty acid content” is clearly supported in Tables 1 and 2 in Arnaud4. Where Table 1 discloses dry fractionated chicken fat with a stearin fraction comprising 43.5% saturated fatty acids and 56.5% unsaturated fatty acids (MUFA+PUFA), and an olein fraction comprising only 27.4% saturated fatty acids and 72.6% unsaturated fatty acids, from pre-fractionated chicken fat comprising 30.3% saturated fatty acids and 69.7% unsaturated fatty acids; and Table 2 discloses dry fractionated chicken fat with a stearin fraction comprising 46.1% saturated fatty acids and 53.9% unsaturated fatty acids (MUFA+PUFA), and an olein fraction comprising only 13.9% saturated fatty acids and 69.7% unsaturated fatty acids, from pre-fractionated chicken fat comprising 33.3% saturated fatty acids and 66.7% unsaturated fatty acids. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ASSAF ZILBERING whose telephone number is (571)270-3029. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Erik Kashnikow can be reached at (571) 270-3475. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ASSAF ZILBERING/Examiner, Art Unit 1792
Read full office action

Prosecution Timeline

Nov 22, 2016
Application Filed
Oct 01, 2018
Non-Final Rejection — §103, §112
Jan 07, 2019
Response Filed
May 13, 2019
Non-Final Rejection — §103, §112
Feb 28, 2020
Response Filed
Jun 09, 2020
Non-Final Rejection — §103, §112
Sep 15, 2020
Response after Non-Final Action
Sep 15, 2020
Response Filed
Dec 18, 2020
Non-Final Rejection — §103, §112
Apr 20, 2021
Response Filed
Aug 17, 2021
Final Rejection — §103, §112
Nov 23, 2021
Response after Non-Final Action
Dec 02, 2021
Response after Non-Final Action
Jan 23, 2022
Request for Continued Examination
Jan 27, 2022
Response after Non-Final Action
Mar 26, 2022
Non-Final Rejection — §103, §112
Jun 20, 2022
Response Filed
Oct 25, 2022
Final Rejection — §103, §112
Jan 10, 2023
Request for Continued Examination
Jan 15, 2023
Response after Non-Final Action
Mar 01, 2023
Non-Final Rejection — §103, §112
Jun 07, 2023
Response Filed
Oct 05, 2023
Non-Final Rejection — §103, §112
Jan 29, 2024
Response Filed
May 28, 2024
Final Rejection — §103, §112
Oct 01, 2024
Interview Requested
Oct 11, 2024
Examiner Interview Summary
Oct 11, 2024
Applicant Interview (Telephonic)
Nov 06, 2024
Request for Continued Examination
Nov 07, 2024
Response after Non-Final Action
Dec 14, 2024
Non-Final Rejection — §103, §112
May 19, 2025
Response Filed
May 21, 2025
Notice of Allowance
Aug 21, 2025
Examiner Interview (Telephonic)
Aug 27, 2025
Response after Non-Final Action
Aug 29, 2025
Response after Non-Final Action
Sep 09, 2025
Non-Final Rejection — §103, §112
Apr 03, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599143
EMULSIFIED OIL AND FAT COMPOSITION
2y 5m to grant Granted Apr 14, 2026
Patent 12588688
METHOD FOR PRODUCING AN INGREDIENT COMPRISING A COMBINATION OF AT LEAST THREE MILK PROTEINS AND USE OF THE INGREDIENT OBTAINED
2y 5m to grant Granted Mar 31, 2026
Patent 12582135
DHA Enriched Polyunsaturated Fatty Acid Compositions
2y 5m to grant Granted Mar 24, 2026
Patent 12577593
DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS
2y 5m to grant Granted Mar 17, 2026
Patent 12564198
METHOD FOR MANUFACTURING SN-2 PALMITIC TRIACYLGLYCEROLS
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

12-13
Expected OA Rounds
33%
Grant Probability
60%
With Interview (+27.2%)
4y 9m
Median Time to Grant
High
PTA Risk
Based on 619 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month